Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adult Patients With Severe Alopecia Areata With an Open-Label Extension Period

NCT07617597 is registered in ClinicalTrials.gov with Sun Pharma Japan Limited as lead sponsor.

NCT NCT07617597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07617597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adult Patients With Severe Alopecia Areata With an Open-Label Extension Period
Lead sponsor
Sun Pharma Japan Limited
Phase
Phase 3
Overall status
Recruiting
Start date
June 19, 2026
Completion date
September 30, 2028
Enrollment
78 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata